Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects From Birth to <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Trial Profile

A Phase III Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects From Birth to <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Dec 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tedizolid (Primary) ; Tedizolid (Primary) ; Cefalexin; Cefazolin; Clindamycin; Clindamycin; Flucloxacillin; Flucloxacillin; Linezolid; Linezolid; Vancomycin
  • Indications Bacterial infections; Cellulitis; Erysipelas; Gram-positive infections; Skin and soft tissue infections; Wound infections
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 19 Mar 2019 Planned End Date changed from 14 Sep 2021 to 18 Sep 2021.
    • 19 Mar 2019 Planned primary completion date changed from 14 Sep 2021 to 18 Sep 2021.
    • 13 Mar 2019 Planned End Date changed from 18 Sep 2021 to 14 Sep 2021.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top